A prospective study of effects of prior osteoporosis treatment on the response to treatment with romosozumab (ROMO) followed by denosumab (DMAb) in patients with postmenopausal osteoporosis
Latest Information Update: 18 Jan 2023
At a glance
- Drugs Denosumab (Primary) ; Romosozumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 01 Jan 2023 Results assessing One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis published in the Calcified Tissue International
- 10 Oct 2022 New trial record